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Patient with Atrial Fibrillation;  
Eligible for Oral Anticoagulation 
Identifies ‘at risk’ patients for more 
regular review and follow-up 
 
For people with an increased risk of bleeding the 
benefit of OAC usually ,but not always, outweighs the 
bleeding risk; thus  careful monitoring of bleeding risk 
is important 
Do not withhold OAC solely because the person is at 
risk of having a fall 
 
EHR and ‘electronic alerts’ 
Low risk=No action 
High risk=Patient ‘flagged up’ for review 
 
‘High risk’ is not a 
reason or excuse to 
withhold OAC 
Review and address potentially 
reversible bleeding risk factors 
- Uncontrolled hypertension 
- Labile INRs (if on VKA) 
- Concomitant use of aspirin and NSAIDs in 
anticoagulated patient 
- Alcohol excess 
 
Bleeding risk assessment 
